Saldanha Ian J, Dickersin Kay, Hutfless Susan T, Akpek Esen K
Departments of *Epidemiology; and †Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ‡Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD; and §Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD.
Cornea. 2017 Dec;36(12):1584-1591. doi: 10.1097/ICO.0000000000001350.
Dry eye, a common yet underrecognized and evolving field, has few recommended treatment algorithms, mostly based on expert consensus rather than robust research evidence. There are high costs associated with managing dry eye and conducting research to identify effective and safe long-term treatments. To support evidence-based management of dry eye, our purpose was to identify and prioritize important clinical research questions for future clinical research.
We translated recommendations from the American Academy of Ophthalmology's 2013 Preferred Practice Patterns for dry eye into answerable clinical research questions about treatment effectiveness. Clinicians around the world who manage patients with dry eye rated each question's importance from 0 (not important) to 10 (very important) using a 2-round online Delphi survey. We considered questions as "important" if ≥75% of respondents assigned a rating of 6 or more in round 2. We mapped the identified important clinical research questions to reliable systematic reviews published up to March 2016.
Seventy-five clinicians from at least 21 countries completed both Delphi rounds. Among the 58 questions, 24 met our definition of "important": 9/24 and 7/24 addressed topical and systemic treatments, respectively. All 4 questions with the highest 25th percentiles addressed topical treatments. Although 6/24 "important" questions were associated with 4 existing reliable systematic reviews, none of these reviews came to a definitive conclusion about treatment effectiveness.
We identified gaps pertaining to treatment options for dry eye. Future clinical research on the management of dry eye should strongly consider these prioritized questions.
干眼症是一个常见但未得到充分认识且不断发展的领域,推荐的治疗算法很少,大多基于专家共识而非有力的研究证据。干眼症的管理以及开展研究以确定有效且安全的长期治疗方法成本高昂。为支持基于证据的干眼症管理,我们的目的是确定未来临床研究的重要临床研究问题并排出优先顺序。
我们将美国眼科学会2013年干眼症首选实践模式中的建议转化为关于治疗效果的可回答的临床研究问题。全球治疗干眼症患者的临床医生通过两轮在线德尔菲调查,将每个问题的重要性从0(不重要)评定到10(非常重要)。如果≥75%的受访者在第二轮中给出6或更高的评分,我们就将这些问题视为“重要”。我们将确定的重要临床研究问题与截至2016年3月发表的可靠系统评价进行了映射。
来自至少21个国家的75名临床医生完成了两轮德尔菲调查。在58个问题中,24个符合我们对“重要”的定义:其中9个和7个分别涉及局部和全身治疗。所有第25百分位数最高的4个问题都涉及局部治疗。虽然24个“重要”问题中有6个与4项现有的可靠系统评价相关,但这些评价均未就治疗效果得出明确结论。
我们确定了干眼症治疗选择方面的差距。未来关于干眼症管理的临床研究应高度考虑这些优先问题。